Marlborough, MA, United States of America

Kathreen A Gifford

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 8.6

ph-index = 8

Forward Citations = 194(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations by Kathreen A Gifford

Introduction

Kathreen A Gifford is a prominent inventor based in Marlborough, MA (US), known for her significant contributions to the field of protein production and purification. With a total of 9 patents to her name, she has made remarkable advancements that have the potential to impact various medical and biotechnological applications.

Latest Patents

Among her latest patents, one notable invention is focused on cell culture methods to reduce acidic species. This invention relates to compositions and processes aimed at controlling the amount of acidic species expressed by host cells, as well as managing the acidic species present in purified preparations. Another significant patent involves low acidic species compositions and methods for producing and utilizing these compositions. This invention includes methods for treating disorders where TNFα is detrimental, showcasing her innovative approach to addressing complex health issues.

Career Highlights

Kathreen has established herself as a key figure in her field, working at AbbVie Inc., where she continues to develop groundbreaking solutions. Her work is characterized by a commitment to enhancing the efficiency and effectiveness of protein production processes.

Collaborations

Throughout her career, Kathreen has collaborated with talented individuals such as Kartik Subramanian and Xiaobei Zeng, contributing to a dynamic and innovative work environment.

Conclusion

Kathreen A Gifford's contributions to the field of protein production and purification through her patents reflect her dedication to innovation and excellence. Her work not only advances scientific knowledge but also holds promise for future medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…